AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

< AHA
Revision as of 19:37, 14 March 2016 by WikiBot (talk | contribs) (Bot: Adding CME Category::Cardiology)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Stroke Main page

Patient Information

Overview

Causes

Classification

Hemorrhagic stroke
Ischemic stroke

Differentiating Stroke from other Diseases

Epidemiology and Demographics

Diagnosis

NIH stroke scale
Glasgow coma scale

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

CDC on AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives in the news

Blogs on AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

2014 AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (DO NOT EDIT)[1]

Class III (Harm)
"1. OCs may be harmful in women with additional risk factors (eg, cigarette smoking, prior thromboembolic events) (Level of Evidence: B) "
"2. Routine screening for prothrombotic mutations before initiation of hormonal contraception is not useful. (Level of Evidence: A) "
Class I
" Measurement of BP before initiation of hormonal contraception is recommended. (Level of Evidence: B) "
Class IIb
" Among OC users, aggressive therapy of stroke risk factors may be reasonable. (Level of Evidence: C)"

References

  1. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL; et al. (2014). "Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. doi:10.1161/01.str.0000442009.06663.48. PMID 24503673.

Template:WS Template:WH CME Category::Cardiology